1. Gazzin S, Vitek L, Watchko J, Shapiro SM, Tiribelli C. A novel perspective on the biology of bilirubin in health and disease. Trends Mol Med. 2016; 22:758–768. PMID:
27515064.
Article
2. Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003; 32:1–22. PMID:
12689998.
Article
3. Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008; 5:e177. PMID:
18752343.
Article
4. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration. Sarwar N, Sandhu MS, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010; 375:1634–1639. PMID:
20452521.
Article
5. Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009; 361:2518–2528. PMID:
20032323.
Article
6. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008; 359:1897–1908. PMID:
18971492.
Article
7. Millwood IY, Walters RG, Mei XW, et al. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet. 2019; 393:1831–1842. PMID:
30955975.
Article
8. Hisamatsu T, Miura K, Tabara Y, et al. Alcohol consumption and subclinical and clinical coronary heart disease: a Mendelian randomization analysis. Eur J Prev Cardiol. 2022; 29:2006–2014. PMID:
35907253.
Article
9. Kim SW, Yang JH, Kweon SS, et al. Association between serum bilirubin and atrial fibrillation: a Mendelian randomization study. Korean Circ J. 2023; 53:472–479. PMID:
37271750.
Article
10. Kang TW, Kim HJ, Ju H, et al. Genome-wide association of serum bilirubin levels in Korean population. Hum Mol Genet. 2010; 19:3672–3678. PMID:
20639394.
Article